Free Trial

AMERISAFE (NASDAQ:AMSF) Posts Quarterly Earnings Results

AMERISAFE logo with Finance background
Remove Ads

AMERISAFE (NASDAQ:AMSF - Get Free Report) released its earnings results on Wednesday. The insurance provider reported $0.67 EPS for the quarter, beating the consensus estimate of $0.60 by $0.07, Zacks reports. The firm had revenue of $73.51 million for the quarter, compared to analysts' expectations of $77.37 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%.

AMERISAFE Stock Up 1.3 %

AMERISAFE stock traded up $0.66 during trading hours on Friday, hitting $51.46. 105,784 shares of the company traded hands, compared to its average volume of 112,794. The firm has a market cap of $980.31 million, a P/E ratio of 16.08 and a beta of 0.35. The firm's 50-day simple moving average is $50.55 and its two-hundred day simple moving average is $51.73. AMERISAFE has a 1-year low of $41.97 and a 1-year high of $60.24.

AMERISAFE Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be paid a dividend of $0.39 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.56 annualized dividend and a yield of 3.03%. AMERISAFE's payout ratio is 51.21%.

AMERISAFE Company Profile

(Get Free Report)

AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.

Featured Articles

Earnings History for AMERISAFE (NASDAQ:AMSF)

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads